@p_gouda1 : 👉25% on concomitant GLP-1RA and SGLT2i with no difference observed in efficacy or safety 👉 injectable is still preferred (⬆️ bioavailability), but will be amazing for our patients who are afraid of injectables • TwiCopy

Pishoy Gouda

@p_gouda1

+ Follow

Interventional #Cardiology Fellow @UAlberta, Passionate about #SoMe and #DigitalMedicine

ID: 2790986564

calendar_today05-09-2014 02:15:23

2,2K Tweet

1,1K Takipçi

1,1K Takip Edilen

Pishoy Gouda

@p_gouda1

5 months ago

👉25% on concomitant GLP-1RA and SGLT2i with no difference observed in efficacy or safety 👉 injectable is still preferred (⬆️ bioavailability), but will be amazing for our patients who are afraid of injectables

thumb_up_off_alt1

chat_bubble_outline0

repeat0

shareShare